Quick-Med Technologies (QMDT) Stock Price
Quick-Med Technologies Price
Revenue has compounded at 38.3% per year over the past 9 years to 928,500.00 USD. Quick-Med Technologies's net margin stands at -76.8%, up from -201.5% several years earlier.
Quick-Med Technologies stock price
Quick-Med Technologies business model & stock analysis
Frequently asked questions about Quick-Med Technologies
The business model of Quick-Med Technologies Inc. focuses on developing and commercializing advanced technologies for infection prevention and control. Quick-Med Technologies Inc. utilizes its proprietary antimicrobial technology to create innovative products that prevent and treat infections. The company's solutions are based on a patented platform technology called NIMBUS®, which is effective against a broad spectrum of microorganisms, including bacteria, viruses, fungi, and other pathogens. Quick-Med Technologies Inc. leverages its expertise in medical-grade antimicrobial technology to provide healthcare professionals and consumers with effective, safe, and cost-efficient infection prevention solutions.
Quick-Med Technologies Inc is primarily active in the healthcare and medical industries.
The main competitors of Quick-Med Technologies Inc in the market include companies such as Johnson & Johnson, 3M Company, and Smith & Nephew plc. These companies also operate in the healthcare and medical technology sectors, offering similar products and services. However, Quick-Med Technologies Inc aims to differentiate itself through its innovative solutions and technologies, providing competitive advantages in the market.
Quick-Med Technologies Inc, a leading biotechnology company, has a rich history and background. Established in [insert year], Quick-Med Technologies Inc has quickly emerged as a pioneer in the field of innovative healthcare solutions. With a focus on developing advanced products for wound care and infection prevention, Quick-Med Technologies Inc has become synonymous with cutting-edge technology and superior quality. The company's unwavering commitment to research and development has led to groundbreaking breakthroughs, enabling it to revolutionize the medical industry. Quick-Med Technologies Inc continues to push boundaries and deliver remarkable solutions, cementing its position as a global leader in the biotechnology sector.
Quick-Med Technologies Inc has achieved several significant milestones. The company successfully developed and commercialized its proprietary antimicrobial technology, which has gained widespread recognition in the healthcare industry. Quick-Med Technologies Inc also secured multiple patents to protect its innovative products and processes. With a strong focus on research and development, the company has made remarkable advancements in the field of antimicrobial technology. Quick-Med Technologies Inc has garnered recognition from various prestigious organizations, including the Wall Street Journal, and continues to strive for excellence in improving infection control measures through its groundbreaking solutions.
Quick-Med Technologies Inc is primarily present in the United States.
Quick-Med Technologies Inc represents a strong commitment to innovation and medical advancements. The company is dedicated to developing cutting-edge technologies in the field of healthcare, aiming to improve patients' lives worldwide. With a focus on research and development, Quick-Med Technologies Inc strives to create effective and safe solutions that address critical medical needs. The company's corporate philosophy is centered around integrity, collaboration, and excellence, aiming to deliver impressive results that positively impact the healthcare industry. Quick-Med Technologies Inc's dedication to advancing medical technologies showcases its commitment to driving progress and making a meaningful difference in the lives of patients and healthcare professionals.
Converted at the current exchange rate, the Quick-Med Technologies share trades at 0.00 EUR (0.00 USD).
Quick-Med Technologies Inc is a company that focuses on the manufacturing and marketing of high-tech technologies that contribute to improving healthcare. The company is based in Gainesville, Florida and has been in the market since 1994. Quick-Med's business model is based on offering innovative technologies that contribute to creating a better world, as well as developing and marketing proprietary products. The company operates in various areas including infection control, wound management, bioactivity, and women's health. One important area that the company operates in is infection control. Quick-Med offers a wide range of antimicrobial technologies and products that help prevent the spread of infections and improve hygiene conditions in various settings. An example is the patient contact antimicrobial dressing, which helps prevent infections from catheters and other medical devices. Another area that Quick-Med operates in is wound management. The company offers a range of products that help wounds heal faster and prevent infections. These include hydrogel dressings, silicone dressings, and other advanced products that help reduce the risk of complications in wound care. Quick-Med is also involved in the field of bioactivity. The company has developed groundbreaking technologies that stimulate biological processes in the body and improve health. These include technologies that support wound healing and technologies that promote bone and tissue regeneration. Another important area that Quick-Med operates in is women's health. The company offers advanced products that help improve women's health. These include technologies that assist in pregnancy prevention and products that contribute to better quality of life for women during menopause. In addition to its various divisions, Quick-Med also provides a range of services. For example, the company offers customized solutions tailored to the needs of its customers. Additionally, the company offers support in product development and clinical trial execution. In summary, Quick-Med Technologies Inc is a company specialized in the development of innovative technologies that help improve the health and well-being of people around the world. Quick-Med operates in various areas including infection control, wound management, bioactivity, and women's health. The company offers a wide range of products and services to meet the needs of its customers.
The revenue cannot currently be calculated for Quick-Med Technologies.
The profit cannot currently be calculated for Quick-Med Technologies.
The P/E ratio cannot be calculated for Quick-Med Technologies at the moment.
The P/S cannot be calculated for Quick-Med Technologies currently.
The Eulerpool Quality Score for Quick-Med Technologies is 2/10.
The ISIN of Quick-Med Technologies is US74837Q1067. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Quick-Med Technologies is 213757. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Quick-Med Technologies is QMDT. The ticker symbol is used to trade Quick-Med Technologies shares on the stock exchange.
Quick-Med Technologies stock
Quick-Med Technologies Peer Group
Quick-Med Technologies FIGI
All fundamentals and in-depth analysis of Quick-Med Technologies
Our stock analysis for Quick-Med Technologies stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Quick-Med Technologies. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.